Pfizer receives FDA approval for haemophilia B gene therapy
Pfizer has received approval from the US Food and Drug Administration (FDA) for its one-time gene therapy BEQVEZ (fidanacogene elaparvovec-dzkt) to treat adults with moderate to severe haemophilia B. Haemophilia B is a rare genetic disorder characterised …